Skip to main content
SpringerLink
Log in

Nephrolithiasis: Current concepts in medical management

  • Published:
Urologic radiology

Abstract

Advances in renal lithiasis research have contributed to a better understanding of the many varied factors that contribute to renal calculus formation. Utilizing the newer techniques of ambulatory metabolic evaluation, we can establish a specific diagnosis in 95% of recurrent stone-formers. Since a significant percentage of initial stone for mers will never have a second episode, it is essential to establish the natural history of the patient’s stone disease prior to initiating potentially life-long medical therapy. The majority of initial stone-formers can be managed with education concerning modest dietary restrictions and increased fluid intake. For the recurrent stone-former with metabolically active stone disease, it is probably best to design medical therapy to treat the specific urinary chemical abnormality or disease process.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Smith LH: Medical treatment of idiopathic calcium urolithiasis.Kidney 16:9–15, 1983

    Google Scholar 

  2. Hiatt RA, Friedman GD: The frequency of kidney and urinary tract diseases in a defined population.Kidney Int 22:63–68, 1982

    Article  PubMed  CAS  Google Scholar 

  3. Johnson CM, Wilson DM, O’Fallon WM, Malek RS, Kurland LT: Renal stone epidemiology: a 25-year study in Rochester, Minnesota.Kidney Int 16:624–631, 1979

    Article  PubMed  CAS  Google Scholar 

  4. Pak CYC: Medical management of nephrolithiasis.J Urol 128:1157–1164, 1982

    PubMed  CAS  Google Scholar 

  5. Pak CYC, Peters P, Hurt G, Kadesky M, Fine M, Reisman D, Splann F, Caramela C, Freeman A, Britton F, Sakhaee K, Breslau NA: Is selective therapy of recurrent nephrolithiasis possible?Am J Med 71:615–622, 1981

    Article  PubMed  CAS  Google Scholar 

  6. Ettinger B: Recurrence of nephrolithiasis: a six year prospective study.Am J Med 67:245–248, 1979

    Article  PubMed  CAS  Google Scholar 

  7. Yendt E: Medical management of calcium stones. In Roth RA, Finlayson B (eds):Stones: Clinical Management of Urolithiasis, Baltimore: Williams and Wilkins, 1983, pp 187–209

    Google Scholar 

  8. Purnell DC, Smith LH, Scholz DA, Elveback LR, Arnaud CD: Primary hyperparathyroidism: a prospective clinical study.Am J Med 50:670–678, 1971

    Article  PubMed  CAS  Google Scholar 

  9. Robertson WG: Risk factors in calcium stone disease. In Brochis G, Finlayson B (eds),International Urinary Stone Conference, Littleton, Massachusetts: PSG Publishing Co., 1979, p 12

    Google Scholar 

  10. Smith LH, VanDenberg CJ, Wilson DM: Current concepts in nutrition: nutrition and urolithiasis.N Engl J Med 298:2:87–89, 1978

    PubMed  CAS  Google Scholar 

  11. Pak CYC, Sakhaee K, Crowther C, Brinkley L: Evidence justifying a high fluid intake in treatment of nephrolithiasis.Ann Intern Med 93:36–39, 1980

    PubMed  CAS  Google Scholar 

  12. Coe FL, Parks JH: Hyperuricosuria and calcium nephrolithiasis. Symposium on Advances of Renal Lithiasis.Urol Clin North Am 8:2:227–244, 1981

    PubMed  CAS  Google Scholar 

  13. Pak CYC, Ohata M, Lawrence EC, Snyder W: The hypercalciurias: causes, parathyroid functions, and diagnostic criteria.J Clin Invest 54:387–400, 1974

    Article  PubMed  CAS  Google Scholar 

  14. Thomas WC Jr: Medical aspects of renal calculus disease. Treatment and prophylaxis.Urol Clin North Am 1:2:261–277, 1974

    PubMed  Google Scholar 

  15. Rubenstein MA, Bucy JG: Acetazolamide-induced renal calculi.J Urol 114:610–612, 1975

    PubMed  CAS  Google Scholar 

  16. Gordon EE, Sheps SG: Effect of acetazolamide on citrate excretion and formation of renal calculi.N Engl J Med 256:1215–1219, 1957

    PubMed  CAS  Google Scholar 

  17. Gregory JG: Hyperoxaluria and stone disease in the gastrointestinal bypass patient.Urol Clin North Am 8:2:331–351, 1981

    PubMed  CAS  Google Scholar 

  18. Lafferty FW: Primary hyperparathyroidism changing clinical spectrum, prevalence of hypertension, and discriminant analysis of laboratory tests.Arch Intern Med 141:1761–1766, 1981

    Article  PubMed  CAS  Google Scholar 

  19. Breslau NA, Pak CYC: Metabolic evaluation. In Roth RA, Finlayson B (eds):Stones: Clinical Management of Urolithiasis, Baltimore: Williams and Wilkins, 1983, pp 168–179

    Google Scholar 

  20. Drach G: Urinary lithiasis: In Harrison JH, Gittes RF, Perlmutter AD, Stamey TA, Walsh PC (eds):Campbell’s Urology Philadelphia: W.B. Saunders 1978, pp 818–819

    Google Scholar 

  21. Finlayson B: Renal lithiasis in review.Urol Clin North Am 1:181–212, 1974

    PubMed  CAS  Google Scholar 

  22. Rose GA: The causes and medical treatment of renal calculi.Practitioner 218:74–80, 1977

    PubMed  CAS  Google Scholar 

  23. Smith L: Stone activity: In Roth RA, Finlayson B (eds):Stones: Clinical Management of Urolithiasis. Baltimore: Williams and Wilkins, 1983, pp 183–186

    Google Scholar 

  24. Finlayson B: Calcium stones: some physical and clinical aspects: In David DS (ed):Calcium Metabolism in Renal Failure and Nephrolithiasis. New York: John Wiley and Sons, 1977, p 371

    Google Scholar 

  25. Menon M: Calcium oxalate stones—management. InUrolithiasis Update 1983. Buffalo, New York: AUA Post-Graduate Course, 1983, p 6

    Google Scholar 

  26. Smith LH: Calcium-containing renal stones.Kidney Int 13:383–389, 1978

    Article  PubMed  CAS  Google Scholar 

  27. Pak CYC, Fetner C, Townsend J, Brinkley L, Northcutt C, Barilla D, Kadesky M, Peters P: Evaluation of calcium urolithiasis in ambulatory patients: comparisons of results with those of inpatient evaluations.Am J Med 64:979–987, 1978

    Article  PubMed  CAS  Google Scholar 

  28. Drach GW, Perin R, Jacobs S: Outpatient evaluation of patients with calcium urolithiasis.J Urol 121:564–567, 1979

    PubMed  CAS  Google Scholar 

  29. Boyce W, Resnick M: Biochemical profiles of stone-forming patients: a guide to treatment.J Urol 121:706–710, 1979

    PubMed  CAS  Google Scholar 

  30. Pak CYC, Britton F, Peterson R, Ward D, Northcutt C, Breslow NA, McGuire J, Sakhaee K, Bush S, Nicar M, Norman D, Peters P: Ambulatory evaluation of nephrolithiasis: classification, clinical presentation and diagnostic criteria.Am J Med 69:19–30, 1980

    Article  PubMed  CAS  Google Scholar 

  31. Coe FL: Nephrolithiasis: causes, classification, and management.Hosp Pract 16:33–45, 1981

    CAS  Google Scholar 

  32. Pak CYC: Kidney stones: various forms and treatment.Nephron 23:142–146, 1979

    Article  PubMed  CAS  Google Scholar 

  33. Pak CYC: Physiological basis for absorptive and renal hypercalciurias.Am J Physiol 237:F414–423, 1979

    Google Scholar 

  34. Pak CYC: A cautious use of sodium cellulose phosphate in the management of calcium nephrolithiasis.Invest Urol 19:187–190, 1981

    PubMed  CAS  Google Scholar 

  35. Nicar MJ, Skurla C, Sakhaee K, Pak CYC: Low urinary citrate excretion in nephrolithiasis.Urology 21:8–14, 1983

    Article  PubMed  CAS  Google Scholar 

  36. Kaplan RA, Haussler MR, Deftos LJ, Bone H, Pak CYC: The role of 1,25-dihydroxycholecalciferol in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria.J Clin Invest 59:756–760, 1977

    Article  PubMed  CAS  Google Scholar 

  37. Coe FL: Hyperuricosuric calcium oxalate nephrolithiasis.Kidney Int 13:418–426, 1978

    Article  PubMed  CAS  Google Scholar 

  38. Coe FL, Raisen L: Allopurinol treatment of uric acid disorders in calcium stone formers.Lancet 1:129–131, 1973

    Article  PubMed  CAS  Google Scholar 

  39. Meyer JL: Nucleation kinetics in the calcium oxalate sodium urate monohydrate system.Invest Urol 19:197–201, 1981

    PubMed  Google Scholar 

  40. Pak CYC, Holt K, Zerwekh JE: Attentuation by monosodium urate of the inhibitory effect of glycosaminoglycans on calcium oxalate nucleation.Invest Urol 17:138–140, 1979

    PubMed  CAS  Google Scholar 

  41. Gregory JG, Park KY, Schoenberg HW: Oxalate stone disease after intestinal resection.J Urol 117:631–634, 1977

    PubMed  CAS  Google Scholar 

  42. Pak CYC, Holt K: Nucleation and growth of brushite and calcium oxalate in urine of stone formers.Metabolism 25:665–673, 1976

    Article  PubMed  CAS  Google Scholar 

  43. Johansson G, Backman U, Danielson BG: Biochemical and clinical effects of the prophylactic treatment of renal calcium stones with magnesium hydroxide.J Urol 124:770–774, 1980

    PubMed  CAS  Google Scholar 

  44. Sakhaee K, Micar M, Jacobson H, Pak CYC: Potassium alkali therapy of uric acid lithiasis may prevent complication of calcium stones (abstract).Clin Res 30:403A, 1982

  45. Bell NH: Hypercalcemic and hypocalcemic disorders: diagnosis and treatment.Nephron 23:147–151, 1979

    Article  PubMed  CAS  Google Scholar 

  46. Brenner RJ, Spring DB, Sebastian A, McSherry EM, Genant HK, Palubinskas AJ, Morris RC: Incidence of radiographically evident bone disease, nephrocalcinosis, and nephrolithiasis in various types of renal tubular acidosis.N Engl J Med 307:217–221, 1982

    Article  PubMed  CAS  Google Scholar 

  47. Yendt ER, Cohanim M: Prevention of calcium stones with thiazides.Kidney Int 13:397–409, 1978

    Article  PubMed  CAS  Google Scholar 

  48. Broadus AE, Thier SO: Metabolic basis of renal-stone disease.N Eng J Med 300:839–845, 1979

    CAS  Google Scholar 

  49. Bogash M, Dowben RM: Low protein diet in the management of recurrent uric acid stones.J Urol 72:1057–1060, 1954

    PubMed  CAS  Google Scholar 

  50. deVries A, Frank M: Prophylaxis of idiopathic and gouty uric acid lithiasis by allopurinol.Urol Int 22:506, 1967

    Article  CAS  Google Scholar 

  51. Thier SO, Segal S: Cystinuria. In Stanbury JB, Wyngarden JB, Fredrickson DS (eds):The Metabolic Basis of Inherited Disease, 4th ed. New York: McGraw-Hill, 1978, pp 1578–1592

    Google Scholar 

  52. Freed SZ: The alternating use of an alkalizing salt and acetazolamide in the management of cystine and uric acid stones.J Urol 113:96–99, 1975

    PubMed  CAS  Google Scholar 

  53. Dahlberg PJ, Van Denberg CJ, Kurtz SB, Wilson DM, Smith LH: Clinical features and management of cystinuria.Mayo Clin Proc 52:533–542, 1977

    PubMed  CAS  Google Scholar 

  54. Griffith DP: Struvite stones.Kidney Int 13:372–382, 1978

    Article  PubMed  CAS  Google Scholar 

  55. Thompson RB, Stamey TA: Bacteriology of infected stones.Urology 2:627–633, 1973

    Article  PubMed  CAS  Google Scholar 

  56. Griffith DP, Moskowitz PA, Carlton CE: Adjunctive chemotherapy of infection-induced staghorn calculi.J Urol 121:711–715, 1979

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Urology, Georgetown University School of Medicine, 3800 Reservoir Road, N.W., 20007, Washington, D.C., USA

    John J. Pahira

Authors
  1. John J. Pahira
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pahira, J.J. Nephrolithiasis: Current concepts in medical management. Urol Radiol 6, 74–79 (1984). https://doi.org/10.1007/BF02923706

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02923706

Key words

Search

Navigation